Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial

Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the study record history. Removed the government-funding notice and Revision: v3.4.1 entry.
    Difference
    0.6%
    Check dated 2026-02-11T02:16:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added to the page, warning that data may not be up to date, and the revision version was updated from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-04T00:40:22.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary visibility is added to the page, and UI highlights now color-code additions in green and deletions in red. The revision stamp updated to Revision: v3.4.0.
    Difference
    0.8%
    Check dated 2026-01-28T00:15:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New entry Revision: v3.3.4 was added and Revision: v3.3.3 was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:56:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry, Revision: v3.3.3, while the HHS Vulnerability Disclosure and the prior Revision: v3.3.2 entry were removed.
    Difference
    0.2%
    Check dated 2025-12-23T14:25:25.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page shows a new revision tag, v3.3.2, replacing the previous v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:51:44.000Z thumbnail image

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.